372 related articles for article (PubMed ID: 31221549)
1. Clinical relevance of skeletal muscle abnormalities in patients with cirrhosis.
Ebadi M; Montano-Loza AJ
Dig Liver Dis; 2019 Nov; 51(11):1493-1499. PubMed ID: 31221549
[TBL] [Abstract][Full Text] [Related]
2. Myosteatosis and sarcopenia are associated with hepatic encephalopathy in patients with cirrhosis.
Bhanji RA; Moctezuma-Velazquez C; Duarte-Rojo A; Ebadi M; Ghosh S; Rose C; Montano-Loza AJ
Hepatol Int; 2018 Jul; 12(4):377-386. PubMed ID: 29881992
[TBL] [Abstract][Full Text] [Related]
3. The additive value of sarcopenia, myosteatosis and hepatic encephalopathy in the predictivity of model for end-stage liver disease.
Lattanzi B; Nardelli S; Pigliacelli A; Di Cola S; Farcomeni A; D'Ambrosio D; Gioia S; Ginanni Corradini S; Lucidi C; Mennini G; Rossi M; Merli M; Riggio O
Dig Liver Dis; 2019 Nov; 51(11):1508-1512. PubMed ID: 31601536
[TBL] [Abstract][Full Text] [Related]
4. Muscle Alterations Are Associated With Minimal and Overt Hepatic Encephalopathy in Patients With Liver Cirrhosis.
Nardelli S; Lattanzi B; Merli M; Farcomeni A; Gioia S; Ridola L; Riggio O
Hepatology; 2019 Nov; 70(5):1704-1713. PubMed ID: 31038758
[TBL] [Abstract][Full Text] [Related]
5. Clinical relevance of sarcopenia in patients with cirrhosis.
Montano-Loza AJ
World J Gastroenterol; 2014 Jul; 20(25):8061-71. PubMed ID: 25009378
[TBL] [Abstract][Full Text] [Related]
6. Sarcopenia and liver transplant: The relevance of too little muscle mass.
Kallwitz ER
World J Gastroenterol; 2015 Oct; 21(39):10982-93. PubMed ID: 26494955
[TBL] [Abstract][Full Text] [Related]
7. The Role of Sarcopenia and Frailty in Hepatic Encephalopathy Management.
Lucero C; Verna EC
Clin Liver Dis; 2015 Aug; 19(3):507-28. PubMed ID: 26195205
[TBL] [Abstract][Full Text] [Related]
8. Limited performance of subjective global assessment compared to computed tomography-determined sarcopenia in predicting adverse clinical outcomes in patients with cirrhosis.
Moctezuma-Velazquez C; Ebadi M; Bhanji RA; Stirnimann G; Tandon P; Montano-Loza AJ
Clin Nutr; 2019 Dec; 38(6):2696-2703. PubMed ID: 30545661
[TBL] [Abstract][Full Text] [Related]
9. Skeletal Muscle Pathological Fat Infiltration (Myosteatosis) Is Associated with Higher Mortality in Patients with Cirrhosis.
Ebadi M; Tsien C; Bhanji RA; Dunichand-Hoedl AR; Rider E; Motamedrad M; Mazurak VC; Baracos V; Montano-Loza AJ
Cells; 2022 Apr; 11(8):. PubMed ID: 35456024
[TBL] [Abstract][Full Text] [Related]
10. Sarcopenia in liver cirrhosis: the role of computed tomography scan for the assessment of muscle mass compared with dual-energy X-ray absorptiometry and anthropometry.
Giusto M; Lattanzi B; Albanese C; Galtieri A; Farcomeni A; Giannelli V; Lucidi C; Di Martino M; Catalano C; Merli M
Eur J Gastroenterol Hepatol; 2015 Mar; 27(3):328-34. PubMed ID: 25569567
[TBL] [Abstract][Full Text] [Related]
11. New concepts in liver cirrhosis: clinical significance of sarcopenia in cirrhotic patients.
Montano-Loza AJ
Minerva Gastroenterol Dietol; 2013 Jun; 59(2):173-86. PubMed ID: 23831908
[TBL] [Abstract][Full Text] [Related]
12. Impact of muscle wasting on survival in patients with liver cirrhosis.
Kalafateli M; Konstantakis C; Thomopoulos K; Triantos C
World J Gastroenterol; 2015 Jun; 21(24):7357-61. PubMed ID: 26139982
[TBL] [Abstract][Full Text] [Related]
13. Review article: prognostic significance of body composition abnormalities in patients with cirrhosis.
Ebadi M; Bhanji RA; Tandon P; Mazurak V; Baracos VE; Montano-Loza AJ
Aliment Pharmacol Ther; 2020 Aug; 52(4):600-618. PubMed ID: 32621329
[TBL] [Abstract][Full Text] [Related]
14. Fat-free muscle mass in magnetic resonance imaging predicts acute-on-chronic liver failure and survival in decompensated cirrhosis.
Praktiknjo M; Book M; Luetkens J; Pohlmann A; Meyer C; Thomas D; Jansen C; Feist A; Chang J; Grimm J; Lehmann J; Strassburg CP; Abraldes JG; Kukuk G; Trebicka J
Hepatology; 2018 Mar; 67(3):1014-1026. PubMed ID: 29059469
[TBL] [Abstract][Full Text] [Related]
15. Risk of falls in patients with cirrhosis evaluated by timed up and go test: Does muscle or brain matter more?
Nardelli S; Gioia S; Ridola L; Carlin M; Cioffi AD; Merli M; Spagnoli A; Riggio O
Dig Liver Dis; 2022 Mar; 54(3):371-377. PubMed ID: 34233863
[TBL] [Abstract][Full Text] [Related]
16. Handgrip Strength Adds More Prognostic Value to the Model for End-Stage Liver Disease Score Than Imaging-Based Measures of Muscle Mass in Men With Cirrhosis.
Sinclair M; Chapman B; Hoermann R; Angus PW; Testro A; Scodellaro T; Gow PJ
Liver Transpl; 2019 Oct; 25(10):1480-1487. PubMed ID: 31282126
[TBL] [Abstract][Full Text] [Related]
17. Severe muscle depletion predicts postoperative length of stay but is not associated with survival after liver transplantation.
Montano-Loza AJ; Meza-Junco J; Baracos VE; Prado CM; Ma M; Meeberg G; Beaumont C; Tandon P; Esfandiari N; Sawyer MB; Kneteman N
Liver Transpl; 2014 Jun; 20(6):640-8. PubMed ID: 24678005
[TBL] [Abstract][Full Text] [Related]
18. Review article: sarcopenia in cirrhosis--aetiology, implications and potential therapeutic interventions.
Sinclair M; Gow PJ; Grossmann M; Angus PW
Aliment Pharmacol Ther; 2016 Apr; 43(7):765-77. PubMed ID: 26847265
[TBL] [Abstract][Full Text] [Related]
19. Sarcopenia in the prognosis of cirrhosis: Going beyond the MELD score.
Kim HY; Jang JW
World J Gastroenterol; 2015 Jul; 21(25):7637-47. PubMed ID: 26167066
[TBL] [Abstract][Full Text] [Related]
20. Clinical impact of sarcopenia assessment in patients with liver cirrhosis.
Marasco G; Dajti E; Ravaioli F; Brocchi S; Rossini B; Alemanni LV; Peta G; Bartalena L; Golfieri R; Festi D; Colecchia A; Renzulli M
Expert Rev Gastroenterol Hepatol; 2021 Apr; 15(4):377-388. PubMed ID: 33196344
[No Abstract] [Full Text] [Related]
[Next] [New Search]
